Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
An Effectiveness and Safety Study of Decitabine in Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis
- Status
- TERMINATED
- Phase
- PHASE3
Addition of Vorinostat to Azacitidine in Higher Risk MDS a Phase II add-on Study in Patients With Azacitidine Failure
- Status
- TERMINATED
- Phase
- PHASE2
Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Spanish Registry of Erythropoietic Stimulating Agents Study
- Status
- COMPLETED
- Phase
- N/A
APG101 in Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE1
ED-TBI Followed By Allogeneic Stem Cell Transplantation For The Treatment Of Refractory AML And Advanced MDS
- Status
- SUSPENDED
- Phase
- PHASE2
Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Pharmacokinetics Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
- Status
- COMPLETED
- Phase
- PHASE2
Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2
Busulfan and Cyclophosphamide Followed By ALLO BMT
- Status
- TERMINATED
- Phase
- NA
A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving
- Status
- COMPLETED
- Phase
- PHASE1
Study With Intravenous Busulfan And Fludarabine Myeloablative Conditioning Regimen For HLA Identical Sibling Donor HSCT
- Status
- COMPLETED
- Phase
- N/A
Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide After Failure of Hypomethylating Agents in Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE2